skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i: I plan to buy some US transportation stocks, or ETFs. Re ETFs: which of XTN (spdr) and IYT (Ishares) do you prefer?
Thanks again, and have a great year. Roland
Read Answer Asked by Roland on December 29, 2014
Q: I am interested in getting into the US market for this years TFSA investment and am thinking of a Canadian ETF which would give me US coverage - what would you recommend.
Read Answer Asked by Paul on December 29, 2014
Q: Hello 5i team

I hold a 4% position and have done quite well seeing a 16% increase while collecting a very nice dividend.

A suit is being brought forward by Credit Unions that failed under the weight of Mortgage-backed Securities they bought from WFC prior to 2009. I have read one article stating WFC remains a buy recommendation with a ratings score of A, and 3 others (including Bernstein) downgrading the bank.

Can you please share any opinion you may have in this matter and what your advice for me moving forward might be - hold or sell.

Thanks for all you do

Gord
Read Answer Asked by Gord on December 27, 2014
Q: I am considering increasing my 1% ownership of Inogen inc---a small company that develops, manufactures and markets oxygen devices for people with chronic breathing problems. Can you comment on this industry/company/management.

thanks---joe
Read Answer Asked by joe on December 25, 2014
Q: Hi Peter and team

What fallout do you see from Express Scripts' decision not to fund Gilead's Hep C drug, not just on Gilead, but on the U.S. biotech sector and healthcare sector? Do you see investors not willing to pay the same for biotech earnings as they have in the past? What stocks and ETFs do you currently recommend for exposure in this sector?

Thanks so much for a wonderful service and best of the season to all!
Read Answer Asked by Mary on December 24, 2014
Q: All the best of the holiday season to everyone at 5i Research.
I was wondering if you could give me any thoughts about Rocky Mountain Chocolate Company?
Read Answer Asked by Gordon on December 24, 2014
Q: Hello
I noticed this new etf and would like your opinion going forward on this or other cyber security stocks.
I assume this would not discount my credit otherwise you do not need to publish
Thanks
Read Answer Asked by Rick on December 24, 2014
Q: May I please have your assessment of AmTrust for adding to my US finacial sector portfolio in a RRSP US$ account . I am looking for share price appreciation rather than income.
Thanks, Tim.
Read Answer Asked by tim on December 24, 2014
Q: Happy Holidays! All the best to you and your families! I currently have a 1.5% weighting in Catamaran and would like to slowly bring it to a full position in my portfolio. Do you feel today's price is a good time to start adding? Also, do you have any suggestions for a cyber security stock in Canada or the US, something like PANW? I have long time frame and high tolerance for risk.
Read Answer Asked by Rob on December 24, 2014
Q: Merry Christmas to all.... And thank you for the great service.
I would appreciate your thoughts on MIC financials ,diversification of the business, and dividend looks ok. to me... but would like your thoughts.. Thanks
Read Answer Asked by don on December 24, 2014
Q: Hi team, Regarding Don's question on NOC....Something to consider is PPA (Aerospace and defense ETF). From Yahoo finance:

Top 10 Holdings (54.03% of Total Assets)
Company Symbol % Assets
Lockheed Martin Corporation Com LMT 6.47
General Dynamics Corporation Co GD 6.38
Honeywell International Inc. Co HON 6.36
Boeing Company (The) Common Sto BA 6.30
United Technologies Corporation UTX 6.25
Northrop Grumman Corporation Co NOC 4.64
Textron Inc. Common Stock TXT 4.53
Raytheon Company Common Stock RTN 4.51
Precision Castparts Corporation PCP 4.48
Rockwell Collins, Inc. Common S COL 4.11
Read Answer Asked by Silvia on December 23, 2014
Q: The reaction of the market to Celgene and Gilead in the wake of ESRX withdrawing support for one of Gilead's products seems rather overdone. I have both of these stocks. is it an opportunity to add more?
Thanks and Merry Xmas
Read Answer Asked by hal on December 23, 2014
Q: FOX appears to be breaking out. How is the valuation? Do you like sector and/or the stock? Merry Christmas. Thanks for all your hard work, Don
Read Answer Asked by Don on December 23, 2014
Q: Hi I am a new member. Wow what a gold mine of information! Here is my first question. I am managing my wife’s LIF and I think it would be prudent to diversify some funds in the US market to capture expected growth and take advantage of the strong US dollar. I am looking at dividend ETF’s (it is a little overwhelming) and wonder which of the following would be my best option;
DVY.US, VIG.US, VYM.US, SDY.US and SCHD.US or will I better off buying individual stocks?
Read Answer Asked by David on December 22, 2014
Q: Can you shed any light on todays precipitous (one third) drop in GILD? Reports only speak of competition,
Read Answer Asked by daniel on December 22, 2014
Q: I would like your opinion on the fundamentals and whether you see this as a long term buy (5years) with steady stable growth? Potential downside here?
Read Answer Asked by Shelley on December 22, 2014
Q: What do you think of LF? The valuation looks attractive, but the market is saying there is something wrong with this co. What am I missing.
Read Answer Asked by Jeremy on December 22, 2014
Q: Hi 5i team,
RAD is up significantly over the past years. Still highly leveraged, the interest rate environment plays in their favor. Restructuring charges seem to be in the past. Their strategy: remodeling stores, wellness rewards program, better buying cost management, etc. seem to be driving same store sales and earnings growth despite the generic drug impact. Demographic evolution of the US population should help. I expect RAD to make its entrance in the S&P500 in a not too distant horizon (2 years? which is well inside my investment horizon). It might look a little expensive, and be a little volatile.
I would like to have your thoughts on the company (including on management). Besides reimbursement program, what are the main threats? Is this a good way to get a first direct exposure to the US economy in a portfolio?
Thank you for your help, Eric
Read Answer Asked by Eric on December 22, 2014